Log In
Print this Print this

Viral PMO-X (AVI-6006)

  Manage Alerts
Collapse Summary General Information
Company Sarepta Therapeutics Inc.
DescriptionRNA-based influenza therapeutic based on morpholino-modified phosphorodiamidate oligomers (PMO) antisense chemistry
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsTreat dengue virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today